Feb 26, 2021 / 05:00PM GMT
Puneet Souda - SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research Analyst
Okay. Great. Welcome, everyone. I'm Puneet Souda, SVB Leerink tools and diagnostic analyst here. And it's a pleasure to be hosting Repligen management team. Joining us from Repligen is Tony Hunt, CEO; and Jon Snodgres, CFO. Hey guys, welcome. Glad to have you here.
Anthony J. Hunt - Repligen Corporation - CEO, President & Director
Puneet, good to see you.
Puneet Souda - SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research Analyst
Great. So just before we get started, I mean, to me, look, Repligen is a high-growth company in the bioprocessing space that is benefiting COVID vaccine ramp and is increasingly seeing growth from high-growth markets of cell and gene therapy. So obviously, a lot to cover here. Please send me questions through the chat if you have any or through e-mail, and we'll cover them during the session.
Repligen Corp at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot